SCHEMBL2984337

SCHEMBL2984337

Cc1ccn2c(NCc3cccc(Cl)c3)c(-c3ccc(Cl)cc3O)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.51
GAA P10253 4/20 0.51
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 2/20 0.51
RAB9A P51151 2/20 0.51
NPC1 O15118 1/20 0.51
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NR1H4 Q96RI1 5/20 0.49
HPGD P15428 2/20 0.48
SIRT1 Q96EB6 1/20 0.46
ATM Q13315 3/20 0.44
PKM P14618 2/20 0.44
PKLR P30613 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2992215 0.94 ALDH1A1 (0.51) MAPTGAAALDH1A1KDM4ERAB9A
SCHEMBL2986401 0.93 MAPT (0.60) MAPTGAAALDH1A1KDM4ERAB9A
SCHEMBL2989780 0.90 MAPT (0.51) MAPTGAAALDH1A1KDM4ERAB9A
SCHEMBL2989095 0.85 MAPT (0.48) MAPTGAAALDH1A1KDM4ERAB9A
SCHEMBL2986422 0.84 NR1H4 (0.47) MAPTGAAALDH1A1KDM4ERAB9A
SCHEMBL2987674 0.84 GAA (0.62) MAPTGAAALDH1A1KDM4ERAB9A
SCHEMBL2990971 0.84 MAPT (0.57) MAPTGAAALDH1A1KDM4ERAB9A
SCHEMBL2989981 0.84 GAA (0.64) MAPTGAAALDH1A1KDM4ERAB9A
SCHEMBL2979689 0.83 NR1H4 (0.54) MAPTGAAALDH1A1KDM4ERAB9A
SCHEMBL2987088 0.82 SIRT1 (0.51) MAPTGAAALDH1A1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US claimed
WO-2008016648-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO claimed
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods TNNC1, TNNI3, TNNT2 MAPT 218/4885GAA 820/4885ALDH1A1 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.